tbuckley/cabot-search huggingface dataset:
The Scientific Program
Journal: JAMA (1961)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Phenome-wide association study of the FIB-4 index in a large, populational-based study in the United States
Authors: Karen Schlauch, Gai Elhanan, Robert Read, Jim Metcalf, Daniel Kiser, Marianne Camargo, Andrew N. Billin, Anand Chokkalingam, Scott Patterson, Robert P. Myers, Joseph J. Grzymski
Journal: Journal of Hepatology (2020)
El Paso Instead of Houston.
Journal: JAMA (1925)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Finalists, The Jeremiah and Rose Stamler Research Award for New Investigators Fatty fish consumption and ischemic heart disease mortality in older adults: The Cardiovascular Health Study
Authors: Dariush Mozaffarian, Rozenn N Lemaitre, Lewis H Kuller, Linda P Fried
Journal: Circulation (2001)

P01 OBJECTIVE. To assess whether dietary intake of fatty fish is associated with a reduced risk of ischemic heart disease mortality in older adults. BACKGROUND. Dietary intake of fatty fish has been associated with a reduced risk of fatal ischemic heart disease in middle-aged men and women. This association, however, has not been specifically evaluated in older adults. METHODS. In 3968 men and women ≥ age 65 enrolled in the Cardiovascular Health Study and free of known cardiovascular disease at baseline, dietary intake of fish (fried fish, tuna fish, and other fish) was assessed through a detailed picture-sort food frequency questionnaire. In a subset of 348 persons, dietary intake of tuna and other fish combined (“fatty fish”) correlated with plasma phospholipid levels of combined docosahexaenoic acid (DHA, 22:6 n-3)) and eicosapentaenoic acid (EPA, 20:5 n-3) (r = 0.40, p &lt; 0.001); intake of fried fish did not correlate with plasma phospholipid levels of these long-chain n-3 fatty acids (r = 0.05, p = 0.37). Participants were prospectively followed for a mean period of 6.8 years for death from ischemic heart disease (incident fatal myocardial infarction [MI] plus coronary heart disease death) and nonfatal MI. FINDINGS. Compared to intake of less than one serving of fatty fish per week, intake of at least one serving of fatty fish per week was associated with a 35% lower risk of death from ischemic heart disease (hazard ratio [HR] 0.65; 95% confidence interval [CI] 0.45 to 0.94) but was not associated with a lower risk of nonfatal MI (HR 0.86; 95% CI 0.64 to 1.15), after adjustment for age, gender, diabetes, smoking status, education, and total caloric intake. CONCLUSIONS. These findings suggest that consumption of at least one serving of fatty fish per week is associated with a lower risk of death from ischemic heart disease in persons aged 65 years and older.
Encore
Authors: None Gemaennes
Journal: Annals of the Rheumatic Diseases (1991)

EncorePregnancy and relapsing polychondritis Relapsing polychondritis is fortunately a rare disease.All the more interesting to see it in a young pregnant woman in her third confinement.Although corticosteroids had to be given to control it, the child came to no harm.The chondritis was seen only in the third pregnancy, but ocular inflammation was seen in both the second and third.
Presenilin-1 polymorphism and Alzheimer's disease
Authors: Patrick Kehoe, Julie Williams, Simon Lovestone, Gordon Wilcock, MichaelJ. Owen, Constantin Bouras, Panteleimon Giannakopoulos, Junichi Schioi, Nikolaos Tezapsidis, NikolaosK. Robakis, Susumu Higuchi, Taro Muramatsu, Sachio Matsushita, Hiroyuki Arai, Hidetada Sasaki, WilliamK. Scott, JohnH. Growdon, AllenD. Roses, JonathanL. Haines, MargaretA. Pericak-Vance
Journal: The Lancet (1996)
THE NEURON IN MEDICINE.
Journal: JAMA (1996)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hepatocyte Transplantation
Authors: John R. Lake
Journal: New England Journal of Medicine (1998)

Attempts to treat a variety of conditions, including type I diabetes mellitus and fulminant liver failure, with epithelial-cell transplantation have been disappointing. In this issue of the Journal, Fox and colleagues report partial correction of the metabolic defect of Crigler–Najjar syndrome type I by transplantation of isolated, allogeneic human hepatocytes.1 They have shown that hepatocyte transplantation is relatively easy to accomplish. Although their report is based on one hepatocyte infusion in one patient, the procedure was safe and relatively inexpensive as compared with orthotopic liver transplantation.Hepatocyte transplantation has been proposed for two types of situations: as “gene therapy” for . . .
Preventive-Care Practices Among Persons With Diabetes—United States, 1995 and 2001
Journal: JAMA (2002)

Effective interventions are available to persons with diabetes that can prevent or delay the development of serious health complications such as lower limb amputation, blindness, kidney failure, and cardiovascular disease. However, the use of preventive-care practices is lower than recommended, and the national health objectives for 2010 aim to improve care for all persons with diabetes. To assess progress toward meeting these goals, CDC analyzed data on selected diabetes-related preventive-care practices, including influenza and pneumococcal vaccination coverage, from the Behavioral Risk Factor Surveillance System (BRFSS) from 1995 and 2001. This report presents the findings of these analyses, which indicate that levels of preventive-care practices among persons with diabetes in the United States increased from 1995 to 2001. Further efforts are needed to improve care among persons with diabetes, reduce the burden of diabetes-related complications, and achieve the national health objectives, including continued surveillance of diabetes-related preventive-care practices and collaboration with community-based organizations, health-care providers, public health officials, and persons with diabetes.
The Cybernetic Man
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Papanicolaou smear testing in elderly women
Authors: G. Kochersberger
Journal: JAMA (1986)

<h3>In Reply.—</h3> Drs Kochersberger and Studenski raise important issues to be considered in designing strategies for screening and disease prevention in the elderly. We are completing a cost-effectiveness analysis of our cervical cancer screening program to address these questions. The analysis tests the effects of varying the uncertain parameters of the natural history of cervical cancer, Papanicolaou smear testing, and quality of life on the cost-effectiveness of the program. There is little information in the literature on cervical carcinoma that is specifically applicable to elderly women. Data do suggest that cervical cancer behaves in a more biologically aggressive manner in older women. The transition time between stages of cervical abnormalities has been observed to elapse four times more rapidly in elderly women compared with younger women.<sup>1</sup>Epidemiologic observations consistent with rapid disease progression in the elderly yield estimates of between three to nine years for progression from normal cervical
Application of HPLC to the Isolation of Molecular Targets in Dosimetry Studies
Authors: Rod Balhorn, J. A. Mazrimas, Michele Corzett
Journal: Environmental Health Perspectives (1985)

High-performance liquid chromatography (HPLC) methods are described which permit the rapid isolation of multiple target macromolecules from the tissues of animals exposed to chemical mutagens. DNA and selected chromosomal proteins are isolated in a simple two step separation scheme. Isolated nuclei are dissolved in 3 M guanidine hydrochloride and the DNA and chromosomal proteins separated on a TSK 3000 SW column. The DNA peak is retained for analysis and the chromatin proteins are dialyzed, lyophylized, and rechromatographed on a PRP-1 column to separate individual histones. Hemoglobin and albumin, two proteins that may prove useful for monitoring mutagen exposure, are isolated from 100 microL of blood by HPLC on a Poly Cat A cation exchange column. Using this approach, we have monitored the kinetics and dose response of adduct formation (and repair) to DNA, histone, hemoglobin and albumin in mice exposed to 7-bromomethylbenzanthracene and benzo[a]pyrene. The results of these studies are described and briefly discussed. Experiments with other mutagens demonstrate the limits to which DNA adduct quantification may be pushed using radioisotopes. Exposures to very high specific activity (200 Ci/mmole) benzo(a)pyrene have allowed DNA adduct quantification down to a few adducts per cell.
Rum Fits and DT's
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Fascicular block and acute myocardial infarction
Authors: M. M. Scheinman
Journal: JAMA (1980)

PROPER treatment of patients with acute myocardial infarction and fascicular block depends on understanding of the relationship between the ventricular specialized conduction system and its blood supply. In this article, we detail the importance of site of infarction, the type of ECG abnormality, and the clinical status of the patient in formulating a rational treatment program. <h3>VENTRICULAR SPECIALIZED CONDUCTION SYSTEM (VSCS) AND ITS BLOOD SUPPLY</h3> The VSCS begins with the branching portion of the His bundle in which fibers segregate into right and left bundle branches (Fig 1). The right bundle-branch (RBB) is long and slender and terminates into a Purkinje network relatively late in its course. In contrast, the left bundle-branch (LBB) divides early into a left anterior fascicle and a left posterior fascicle.<sup>1</sup>Special fibers derived from the left conducting system activate the septum. The blood supply to the His bundle is usually dual,<sup>2</sup>arising from
Coding Error and Change in Secondary Outcome Results
Journal: JAMA (2017)

Anny H. Xiang, PhD; Xinhui Wang, MS; Mayra P. Martinez, MPH; Johanna C. Walthall, PhD; Edward S. Curry, MD; Kathleen Page, MD; Thomas A. Buchanan, MD; Karen J. Coleman, PhD; Darios Getahun, MD, PhD
QLIF-11. WITHDRAWAL OF ANTIEPILEPTIC DRUGS IN GLIOMA PATIENTS AFTER LONG-TERM SEIZURE FREEDOM
Authors: Melissa Kerkhof, Johan A F Koekkoek, Maaike J Vos, Martin van den Bent, Walter Taal, Tjeerd J Postma, Jacolien EC Bromberg, Mathilde Kouwenhoven, Linda Dirven, Jaap C Reijneveld, Martin JB Taphoorn
Journal: Neuro-Oncology (2017)

When glioma patients experience long-term seizure freedom the question arises whether antiepileptic drugs (AEDs) should be continued. We performed a prospective study on the decision-making process to withdraw AEDs in glioma patients with long-term seizure freedom, and on seizure outcome after withdrawal. Patients with a histologically confirmed low grade or anaplastic glioma were included. Patients eligible for the study were seizure free for ≥ 1 year counted from the date of last surgery, irradiation or chemotherapy, or ≥ 2 years since the last seizure after antitumor treatment. Primary outcome measures were: 1) the outcome of the shared-decision making process (i.e. AED withdrawal or continuation) and 2) the rate of successful AED withdrawal. Between January 2014 and December 2016, 83 patients fulfilled all eligibility criteria. In 12/83 (14%) of patients, the neuro-oncologist had serious objections to AED withdrawal. Therefore, 71/83 (86%) were included in the study. In 46/71 (65%) patients AEDs were withdrawn and in 25/71 (35%) AEDs were continued. Median follow-up was 2.0 years (range 0.8-3.8). Twenty-six percent (12/46) had seizure recurrence during-follow up; six of these twelve patients (50%) had tumor progression, of which three patients had tumor progression within three months after seizure recurrence. Median time of tumor progression after seizure recurrence is 8.5 months (range: 0.2-19 months). Eight patients had a focal seizure, three patients a generalized seizure and one patient had a complex-partial status epilepticus. In the AED continuation group, none of the patients had seizure recurrence. In this group one patient had tumor progression. Sixty-five percent of selected patients preferred to withdraw their AEDs, of which 26% had seizure recurrence. AED withdrawal should only be considered in carefully selected patients.
Sudden Death
Authors: Peter T. Kuo
Journal: JAMA (1981)

This publication represents a compilation of currently available basic and clinical information on the challenging subject of sudden death. It contains the proceedings of a conference held in Liége, Belgium. The chapters are contributed by experts in diverse disciplines in cardiology from seven countries and are divided into five sections: the epidemiology and pathology of sudden death, the electrophysiology of lethal arrhythmias, the indicators of high risk for sudden death, prevention, and sudden death in noncoronary heart disease. It is generally known that a high percentage of sudden deaths occur before medical examination is possible. Sudden death in young women is primarily related to heavy smoking or use of estrogens in those at high risk for coronary artery disease. Among them, a high prevalence of psychiatric disorder is also noted. For some reason, patients of low socioeconomic level appear to show increased susceptibility to sudden death. The pathological basis of
Continuing Education Courses for Physicians
Authors: Rutledge W. Howard
Journal: JAMA (1972)

For the first time, this year's course listing is published as a supplement to<i>JAMA</i>and is being mailed with this issue. In the belief that all known institutions andorganizations offering programs of continuing medical education in the United States have had an opportunity to request a survey for accreditation of their continuing medical education programs, the AMA Council on Medical Education in June 1971, upon the recommendation of its Advisory Committee on Continuing Medical Education, took the following action: beginning with this year's course listing, only the continuing medical education activities of institutions and organizations that have been accredited for their programs of continuing medical education will be listed. Because this is a transition year in the course listing and because some institutions and organizations could not be surveyed in time for their accredited status to be determined, the course listing also includes the names of those institutions and
SECTION ON MATERIA MEDICA AND PHARMACY.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Office Surgery.
Journal: JAMA (1933)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Comparison of 1D, 2D, 3D and volumetric parameters in measuring tumor response in high-grade gliomas in adults
Authors: G. Shah, S. Kesari, R. Xu, J. Henson, T. Batchelor, F. Hochberg, A. Oneill, B. Levy, J. Bradshaw, P. Y. Wen
Journal: Journal of Clinical Oncology (2004)

1523
Correction
Journal: BMJ (1963)

antitoxin injected in the event of injury-is well worth all the inconvenience. Duration of Immunity and Reinforcing DosesWhen primary immunization has been done in infancy reinforcement of immunity is begun with the DTP dose qt 15 to 18 months and continued by doses of DT/Vac at school-entry and 8 to 10 years.A further dose of Tet/Vac at school-leaving age will maintain protection for many years, if not for life.When primary immunization is not done until during school-life or adolescence reinforcing doses (at least two or three) of tetanus toxoid are necessary at roughly five- year intervals.Thereafter a dose of toxoid in the event of injury will suffice to raise effectively the level of protec- tion.